Stephens Inc. AR Purchases 344 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Stephens Inc. AR increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 5.6% during the third quarter, HoldingsChannel reports. The fund owned 6,476 shares of the company’s stock after buying an additional 344 shares during the quarter. Stephens Inc. AR’s holdings in HealthEquity were worth $530,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. 1620 Investment Advisors Inc. bought a new stake in HealthEquity during the 3rd quarter worth $112,000. New York State Teachers Retirement System lifted its holdings in HealthEquity by 1.4% during the 3rd quarter. New York State Teachers Retirement System now owns 83,997 shares of the company’s stock worth $6,875,000 after buying an additional 1,146 shares during the period. Nisa Investment Advisors LLC lifted its holdings in HealthEquity by 19.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 3,420 shares of the company’s stock worth $280,000 after buying an additional 566 shares during the period. State of Alaska Department of Revenue lifted its holdings in HealthEquity by 7.2% during the 3rd quarter. State of Alaska Department of Revenue now owns 10,146 shares of the company’s stock worth $830,000 after buying an additional 685 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in HealthEquity by 18.8% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company’s stock worth $299,000 after buying an additional 578 shares during the period. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

HQY has been the topic of several recent research reports. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Barrington Research reissued an “outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Finally, Bank of America dropped their price objective on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $103.83.

HealthEquity Stock Up 9.8 %

HQY stock opened at $97.95 on Thursday. The stock’s 50 day simple moving average is $82.36 and its 200 day simple moving average is $80.19. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $99.00. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The company has a market cap of $8.55 billion, a P/E ratio of 81.63, a price-to-earnings-growth ratio of 1.36 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. The firm had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. On average, research analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now directly owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.